The latest news from academia, regulators
research labs and other things of interest
Posted: February 26, 2008
Arrowhead Conferences' 2nd Annual Drug Delivery Summit to Take Place May 1st-2nd, 2008
(Nanowerk News) Arrowhead Publishers and Conferences is proud to announce that it is hosting its 2nd Annual Drug Delivery Summit: New Technologies and Commercialization Trends in San Francisco, California on May 1st and 2nd, 2008.
Background and Focus:
As competition in the pharmaceutical marketplace grows, companies are increasingly looking towards the drug delivery industry to maximize revenues and combat generic competitors. The drug delivery industry has in recent years become a key partner for pharmaceutical companies in their efforts to maximize the patent lives of successful products. Drug delivery companies not only stand to benefit from patent expiry by providing their reformulation services to pharmaceutical companies, but also by producing their own versions of branded products with improved delivery mechanisms.The current value of the drug delivery market has been estimated at over USD$65 billion.
Arrowhead's 2nd Annual Drug Delivery Summit will provide a forum for leaders from both the drug delivery and pharmaceutical industry to discuss the challenges and opportunities facing the development of new drug delivery technologies and therapies utilizing cutting-edge drug delivery technologies. This conference will not only assess new drug delivery systems and technologies, but will provide instruction and case studies on successful licensing and deal-making in this sector.
With sessions covering both the technical and business sides of the industry, this conference has been organized with both the scientist and business professional in mind.
Key themes of this conference will include:
An examination of key emerging technologies in the following areas:
- controlled release
- RNAi delivery
- and other modes of drug delivery
Keys to the formation of successful alliances
Unlocking the door to delivery of macromolecules
Mapping of bioavailability as a key to successful formulation
Overcoming first pass metabolism and absorption window problems
Patent and IP protection in drug delivery
Considerations and best practices in contract manufacturer-drug delivery partnerships
Trends in tumor and organ targeting
Making the deal - structuring mutually beneficial licensing arrangements
For more information about this conference, please visit http://www.arrowheadpublishers.com/conferences/drugdelivery2008/